Read Summary

Preoperative immune-modulating nutrition (IMN) in patients undergoing surgery for gastrointestinal cancer reduces the risk of infectious complications and shortens hospital stays, according to a new systematic review and meta-analysis.
Reuters Health Information

Print Friendly, PDF & Email